AGILENT TECHNOLOGIES INC

Agilent Technologies’ recent Rule 144 sale and conflict‑minerals disclosure highlight its strong market position and commitment to ethical sourcing in life‑sciences tools.

Agilent Technologies Inc. is a strategic powerhouse in the life sciences industry, driving innovation and growth through its cutting-edge solutions, financial acumen, and commitment to emerging markets such as mass spectrometry and cancer diagnostic…

Agilent Technologies Inc. has received FDA approval for its MMR IHC Panel pharmDx, a companion diagnostic test for colorectal cancer, marking a significant advancement in the treatment of mismatch repair deficient patients.

Agilent Technologies’ recent earnings report and market performance have raised questions about the company’s valuation and ability to sustain its growth trajectory in a competitive life sciences sector.